Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol vs Dexamethasone Post-Strabismus Surgery
NCT02825186Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Jul 2016
- Primary completion
- Jun 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of loteprednol etabonate ophthalmic gel 0.38% in post-operative inflammation and postoperative pain (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Intraocular pressure at 4 weeks and Conjunctival hyperemia at 4 weeks. Status: unknown.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
post-operative inflammationpostoperative pain
Beyond the preview
Go deeper on NCT02825186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825186.